Wait for galactosemia therapy goes on after FDA shuns Applied Therapeutics’ govorestat
The US Food and Drug Administration has declined to approve Applied Therapeutics’ govorestat for classic galactosemia.
The US Food and Drug Administration has declined to approve Applied Therapeutics’ govorestat for classic galactosemia.
What's Your Reaction?
